National Healthcare CORP Stock: price and directors' dealings · United States · SEC (Form 4)Track the National Healthcare CORP share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, National Healthcare CORP has published 201 reports. Market capitalisation: €3.5bn. The latest transaction was filed on 28 August 2026 (Cession). Among the most active insiders: Flatt Stephen Fowler. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,999 of 29,062 companies
FCF yld 4.4%
Earn yld 3.5%
EV/EBITDA 16.3x
ROE 13%
Gross mgn 39%
Net mgn 7.9%
Debt/EBITDA 0.4x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
All Executives201 Thresholds0 Prospectus0 Other0
Declarations 201 total
▼ Director · Executives · 25 Aug 2026
1,779 shares @ US$225.42 Common Stock SEC:0001437749-26-029198:0
◇ Director · Executives · 20 Aug 2026
6,479 shares @ US$171.42 0.030% mcap 46.3% of flow Common Stock SEC:0001437749-26-028735:0
◆ Director · Executives · 20 Aug 2026
4,691 shares @ US$236.75 0.030% mcap 46.3% of flow Common Stock SEC:0001437749-26-028735:1
▼ CEO · Executives · 19 Aug 2026
1,500 shares @ US$237.08 0.0097% mcap 5.8% of flow Common Stock SEC:0001437749-26-028642:0
◇ Director · Executives · 13 Aug 2026
1,021 shares @ US$171.42 0.0050% mcap 100.0% of flow Common Stock SEC:0001437749-26-028203:0
▼ Director · Executives · 22 Jun 2026
5,937 shares Shares of Common Stock SEC:0001437749-26-021438:0
◇ Director · Executives · 8 Jun 2026
4,000 shares Shares of Common Stock - Trust I SEC:0001437749-26-020163:0
● Director · Executives · 8 Jun 2026
4,000 shares Shares of Common Stock - Trust I SEC:0001437749-26-020163:1
◇ Senior VP & CIO · Executives · 22 May 2026
4,000 shares @ US$94.10 0.011% mcap 6.2% of flow Common Stock SEC:0001437749-26-018587:0
● Senior VP & CIO · Executives · 22 May 2026
2,739 shares @ US$196.00 0.015% mcap 8.9% of flow Common Stock SEC:0001437749-26-018587:1
◇ Director · Executives · 30 Apr 2026
7,500 shares @ US$71.64 0.015% mcap 11.6% of flow Shares of Common Stock SEC:0001437749-26-014489:0
● Sr.VP Patient Srvcs · Executives · 22 Apr 2026
2,853 shares @ US$173.63 0.014% mcap 19.2% of flow Shares of Common Stock held in my name SEC:0001437749-26-013316:1
◇ Sr.VP Patient Srvcs · Executives · 22 Apr 2026
4,000 shares @ US$94.10 0.011% mcap 14.6% of flow Shares of Common Stock held in my name SEC:0001437749-26-013316:0
● Senior VP & CIO · Executives · 9 Apr 2026
2,109 shares @ US$176.81 0.010% mcap 8.7% of flow Common Stock SEC:0001437749-26-012253:0
◇ Senior VP & CIO · Executives · 9 Apr 2026
3,734 shares @ US$53.94 3.0% of flow Common Stock SEC:0001437749-26-012168:0
● Senior VP & CIO · Executives · 9 Apr 2026
1,909 shares @ US$176.81 5.1% of flow Common Stock SEC:0001437749-26-012168:1
◇ Sr.VP Patient Srvcs · Executives · 16 Mar 2026
3,734 shares @ US$53.94 8.1% of flow Shares of Common Stock held in my name SEC:0001437749-26-008849:0
◇ CEO · Executives · 12 Mar 2026
1,853 shares @ US$53.94 2.0% of flow Common Stock SEC:0001437749-26-008414:0
◇ SVP, CFO · Executives · 12 Mar 2026
1,853 shares @ US$53.94 8.2% of flow Common Stock SEC:0001437749-26-008408:0
◇ Director · Executives · 9 Mar 2026
3,140 shares @ US$55.75 0.0050% mcap 11.4% of flow Shares of Common Stock SEC:0001437749-26-007533:0
◇ Sr.VP Patient Srvcs · Executives · 4 Mar 2026
4,500 shares @ US$90.62 12.1% of flow Shares of Common Stock held in my name SEC:0001437749-26-007216:0
◇ Senior VP & CIO · Executives · 4 Mar 2026
3,733 shares @ US$53.94 4.1% of flow Common Stock SEC:0001437749-26-007213:0
◇ SVP, CFO · Executives · 4 Mar 2026
2,000 shares @ US$53.94 6.1% of flow Common Stock SEC:0001437749-26-007207:0
◇ Senior VP & General Counsel · Executives · 4 Mar 2026
4,500 shares @ US$90.62 18.6% of flow Common Stock SEC:0001437749-26-007211:0
◇ Sr.VP Operations · Executives · 4 Mar 2026
2,667 shares @ US$94.10 30.4% of flow Common Stock SEC:0001437749-26-007209:0
25 of 201 declarations
Load more (176 remaining) 关于 National Healthcare CORP National HealthCare Corporation (NHC) 是一家总部位于美国的医疗保健运营商,在纽约证券交易所美国市场上市,股票代码为NHC。该公司成立于1971年,总部位于田纳西州默弗里斯伯勒,已发展成为一个专注于急性后期和长期护理的综合性老年护理平台。其核心业务涵盖专业护理机构、辅助生活社区、独立生活设施、家庭护理机构、临终关怀服务和行为健康医院。NHC还通过管理服务、会计和金融服务、保险服务以及与某些医疗保健资产相关的物业租赁收入等相关辅助活动产生收入。
从行业角度来看,NHC处于更广泛的美国老年住房和急性后期护理领域,其中运营执行、临床质量、报销组合和劳动力管理至关重要。该公司的模式在护理环境中是多样化的,但其经济引擎仍然与住院老年护理和急性后期服务相关。这使得NHC不像一个纯粹的房地产或纯粹的急性护理公司,而更像一个垂直整合的医疗保健运营商,面临着人口老龄化带来的持续需求。
从地理上看,NHC在美国多个州拥有重要的区域足迹,尤其在东南部地区,包括田纳西州、南卡罗来纳州、北卡罗来纳州、佛罗里达州和弗吉尼亚州,拥有强大的市场份额。这种区域集中度可能是有利的,因为它支持转诊关系、人员配备深度以及对各州特定报销和许可制度的运营熟悉度。同时,该业务受制于高度监管的环境,报销、人员配备和合规标准可能会严重影响利润率和增长。
在竞争方面,NHC通过服务广度、运营纪律和设施质量的结合来区分自己,而不仅仅是规模。该公司强调其专业护理组合的相对较高评级,这在一个质量指标影响转诊流量、付款人信心和家庭决策的行业中至关重要。NHC的业务还得到保险和管理服务等辅助能力的支持,这为其盈利基础增加了一些多样性。
最近的一项重大进展是于2024年8月1日收购了White Oak。该交易增加了南卡罗来纳州和北卡罗来纳州的15家专业护理机构、两家辅助生活机构、四家独立生活机构和一家长期护理药房。该交易扩大了NHC的运营基础,并有助于推动2025年的业绩,因为该公司受益于White Oak的全年运营。然而,该公司也指出与收购相关债务相关的利息支出增加,以及其自保业务中不利的索赔活动。对于投资者而言,NHC仍然是纽约证券交易所美国市场上市的美国医疗保健公司,具有防御性、人口驱动的投资主题,但受到报销敏感性和高度监管行业中执行风险的制约。